Evidence map›Paper›PMID 31331920›Full record

ArticleBlood2019

Antibiotics inhibit tumor and disease activity in cutaneous T-cell lymphoma.

Lise M Lindahl, Andreas Willerslev-Olsen, Lise M R Gjerdrum, Pia R Nielsen, Edda Blümel, Anne H Rittig, Pamela Celis, Bjorn Herpers, Jürgen C Becker, Birgitte Stausbøl-Grøn and 21 more

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Blood, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07781449 (An Investigator-Initiated, Descriptive, Proof-of-Concept, Open-Label Pilot Study Focusing on Topical JAK Inhibition as a Novel Treatment of Cutaneous T-Cell Lymphoma), which is not on this map. Cited by 76 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed, 1 pooled it
16.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07781449 phase2not yet recruitingnot on this mapstarted 2026, after this paper: background citation

An Investigator-Initiated, Descriptive, Proof-of-Concept, Open-Label Pilot Study Focusing on Topical JAK Inhibition as a Novel Treatment of Cutaneous T-Cell Lymphoma

TypeinterventionalSponsorAarhus University HospitalRan2026 to 2030Enrolled15ConditionsMycosis Fungoides, Cutaneous T-cell LymphomaArmsdelgocitinib
3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 1 synthesis or guideline pooled it, 133 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Successful Multimodal Therapeutic Approach for CD30-positive Folliculotropic Mycosis Fungoides.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. The skin microbiome in dermatologic disease.Journal of the American Academy of Dermatology · 2025
    Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

31 authors at 9 institutions in 4 countries.

Lise M LindahlDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Andreas Willerslev-OlsenLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Lise M R GjerdrumDepartment of Pathology, Zealand University Hospital, Roskilde, Denmark.ORCID 0000-0003-4377-3209
Pia R NielsenDepartment of Pathology, Zealand University Hospital, Roskilde, Denmark.ORCID 0000-0002-7797-3949
Edda BlümelLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-3270-9466
Anne H RittigDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.ORCID 0000-0001-7983-8671
Pamela CelisDepartment of Molecular Medicine, Aarhus University, Aarhus, Denmark.
Bjorn HerpersRegional Public Health Laboratory Kennemerland, Haarlem, The Netherlands.
Jürgen C BeckerDepartment of Translational Skin Cancer Research, German Cancer Consortium, Dermatology, University Hospital of Essen, Essen, Germany.ORCID 0000-0001-9183-653X
Birgitte Stausbøl-GrønDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Mariusz A WasikDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA.
Maria GluudLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Simon FredholmLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Terkild B BuusLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0001-7180-6384
Claus JohansenDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Claudia NastasiLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Lukas PeifferDepartment of Translational Skin Cancer Research, German Cancer Consortium, Dermatology, University Hospital of Essen, Essen, Germany.
Linda KubatDepartment of Translational Skin Cancer Research, German Cancer Consortium, Dermatology, University Hospital of Essen, Essen, Germany.
Michael BzorekDepartment of Pathology, Zealand University Hospital, Roskilde, Denmark.
Jens O EriksenDepartment of Pathology, Zealand University Hospital, Roskilde, Denmark.
Thorbjørn KrejsgaardLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Charlotte M BonefeldLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
Carsten GeislerLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-8472-0771
Tomas MustelinDivision of Rheumatology, Department of Medicine, University of Washington, Seattle, WA.
Erik LanghoffJames J. Peters VA Medical Center, Veterans Affairs, Bronx, New York, NY; and.
Michael GivskovCosterton Biofilm Center, University of Copenhagen, Copenhagen, Denmark.
Anders WoetmannLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-3008-735X
Mogens KilianDepartment of Biomedicine, Aarhus University, Aarhus, Denmark.ORCID 0000-0002-5861-0472
Thomas LitmanLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0002-6068-901X
Lars IversenDepartment of Dermatology, Aarhus University Hospital, Aarhus, Denmark.
Niels OdumLEO Foundation Skin Immunology Research Center, Department of Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.ORCID 0000-0003-3135-5624
University of Copenhagen · DKAarhus University Hospital · DKZealand University Hospital · DKEssen University Hospital · DEAarhus University · DKJames J. Peters VA Medical Center · USSpaarne Gasthuis · NLUniversity of Pennsylvania · USUniversity of Washington · US

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
NCI NIH HHS P30 CA006927
6 · The paper itself

Abstract

It has been proposed that CD4 T-cell responses to

Indexed as

AgedAnti-Bacterial AgentsCell ProliferationFemaleHumansLymphoma, T-Cell, CutaneousMaleMiddle AgedProspective StudiesSignal TransductionSkin NeoplasmsSTAT3 Transcription FactorT-LymphocytesAnti-Bacterial AgentsSTAT3 protein, humanSTAT3 Transcription Factor

Identifiers

PMID31331920
PMCPMC6764271
OpenAlexW2962823845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.